Tong Zhang

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Cardiovascular Events

Skeletal Muscle

Top Venues

Diabetes, metabolic syndrome and obesity : targets and therapy

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Xuehe Zhang, Fen Liu, Wenling Li, Jixin Zhang, Tong Zhang, Xiaolin Yu, Junyi Luo, Qian Zhao, Jinyu Zhang, Binbin Fang, Yi-Ning Yang, Xiaomei Li
Metabolic Score for Insulin Resistance (METS-IR) Predicts Adverse Cardiovascular Events in Patients with Type 2 Diabetes and Ischemic Cardiomyopathy. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Xuehe Zhang, Fen Liu, Wenling Li, Jixin Zhang, Tong Zhang, Xiaolin Yu, Junyi Luo, Qian Zhao, Jinyu Zhang, Binbin Fang, Yi-Ning Yang, Xiaomei Li
Metabolic Score for Insulin Resistance (METS-IR) Predicts Adverse Cardiovascular Events in Patients with Type 2 Diabetes and Ischemic Cardiomyopathy. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Xuehe Zhang, Jixin Zhang, Fen Liu, Wenling Li, Tong Zhang, Binbin Fang, Zhiyang Zhang, Qian Xie, Yi-Ning Yang, Xiaomei Li
Prognostic Nutritional Index (PNI) as a Predictor in Patients with Metabolic Syndrome and Heart Failure. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Xuehe Zhang, Fen Liu, Wenling Li, Jixin Zhang, Tong Zhang, Xiaolin Yu, Junyi Luo, Qian Zhao, Jinyu Zhang, Binbin Fang, Yi-Ning Yang, Xiaomei Li
Metabolic Score for Insulin Resistance (METS-IR) Predicts Adverse Cardiovascular Events in Patients with Type 2 Diabetes and Ischemic Cardiomyopathy. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Jun-Yi Luo, Fen Liu, Bin-Bin Fang, Ting Tian, Yan-Hong Li, Tong Zhang, Xiao-Mei Li, Yi-Ning Yang
NFKB1 Gene Mutant Was Associated with Prognosis of Coronary Artery Disease and Exacerbated Endothelial Mitochondrial Fission and Dysfunction. Oxidative medicine and cellular longevity 2022 (2022)